医院管理学习：如何选择急性髓系白血病的治疗： 自体移植还是异基因移植？中国医学科学院血液病医院实践（PPT课件）.pptxVIP

实践案例：中国医学科学院血液病医院;NCCN 2016年指南推荐;;NPM1;CEBPα Mutations in AML;FLT3 Mutations in AML;TP53 mutations in AML;;9;;Patients with t(8;21)(q22;q22) AML generally have a favorable prognosis. With intensive induction chemotherapy, nearly all individuals will achieve a morphologic CR, and with repeated courses of intensive consolidation therapy, the relapse risk may not exceed 20% to 35% in 3 to 5 years. Consequently, these patients have, on average, no survival advantage with allo-HCT while in first remission because TRM is greater than the decrease in relapse rates afforded by the transplant. How